Company intelligence / Profile preview

Vibrac

Carros, France

Ownership: Private
Employees: ~5100
Development stage: Other

Overview

Virbac is a global veterinary biopharma group marketing a wide range of commercialized products for prevention, diagnosis and treatment of diseases in more than 50 animal species, with ongoing R&D in biologicals, pharmaceuticals, diagnostics, petfood and pet care.

Therapeutic areas: OtherDermatologyInfectious Diseases
Modalities: VaccineBiologicSmall moleculeDevicePet foodDiagnostics
Industry: Veterinary

Partnerships

Partnerships with universities and public/private research laboratoriesCollaborations with biotech companies for new technologiesExamples include collaborations around cell therapies and other innovations, though partners are described generally rather than in a comprehensive list

Beyond the preview

Go deeper on Vibrac.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vibrac.

Explore the full profile